Detalhe da pesquisa
1.
In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab')2.
J Infect Dis
; 220(1): 41-45, 2019 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852585
2.
Exploiting the Legacy of the Arbovirus Hunters.
Viruses
; 11(5)2019 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31126128
3.
Immunogenicity of a thermally inactivated rotavirus vaccine in mice.
Hum Vaccin
; 4(2): 143-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18382129
4.
Rational design of rabies vaccine formulation for enhanced stability.
Turk J Med Sci
; 47(3): 987-995, 2017 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618756
5.
Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir.
Immunotherapy
; 8(9): 1021-32, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380317
6.
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
Pediatr Infect Dis J
; 23(2): 99-109, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14872173
7.
Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.
Am J Trop Med Hyg
; 66(3): 264-72, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12139219
8.
Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice.
Immunotherapy
; 6(6): 699-708, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24673720
9.
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.
Vaccine
; 24(9): 1238-41, 2006 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-16213632
10.
Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis.
Adv Virus Res
; 61: 419-43, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14714439